Physiology, Ocular Completed Phase 2 Trials for Moxaverine (DB12251)
Also known as: Ocular Physiology
| Indication | Status | Phase |
|---|---|---|
| DBCOND0042512 (Physiology, Ocular) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00709423 | Effects of Moxaverine and Placebo on Ocular Blood Flow | Treatment |